Taken together, these studies indicate that TPC2 is highly expressed in hepatocellular carcinoma, oral squamous cell carcinoma and blood cancers, however, whether this expression is observed in additional cancer types, remains to be seen. This evidence concerns the gene TPCN2 and cancer.